Kotak Fund to invest ₹1,600 crore in Nimmagadda Prasa

Kotak Strategic Situations Fund (KSSF) plans to invest around ₹1,600 crore in the active pharmaceutical ingredients (API) business acquired by Nimmagadda Prasad. The fund will support the acquisition through a $200 million funding, provided through a mix of structured debt and equity. Deutsche Bank and DBS have also reportedly financed the acquisition.

Related Keywords

Sanghi , Haryana , India , Kozhikode , Kerala , Mumbai , Maharashtra , Nimmagadda Prasad , Kotak Strategic Situations Fund , Healthcare Management Analytics Programme , Iquest Enterprises , Kotak Special Situation Fund , Sanghi Industries , Gold Plus Glass Industry Ltd , Offering College , Biocon , Chain Solutions , Deutsche Bank , Kotak Group , Spokespersons Of Iquest Enterprises , Healthcare Expertise , Matrix Laboratories , Kotak Investment Advisors , Sify Infinit Spaces , Investment Advisors , Famy Care , Kotak Fund , Api Business , Kssf , Dcw , Tvs Supply Chain Solutions , Ags Transact Technologies ,